SST hypermethylation, with subsequent decrease in gene expression, has been observed in 81% of HNSCC samples and has been linked to tumor extent, disease stage, galanin type 2 receptor (GALR2) methylation, and tachykinin-1 (TAC1) methylation [35]. This evidence concerns the gene GALR2 and neoplasm.